Now that gene expression microarray experiments are routine, the challenge is to extract accurate intelligence from the data they produce. The problem isn’t inaccuracies in the analysis software or ...

A new study by 64 renowned scientists may bring us one step closer to personalized medical treatment--that is, medical treatment tailored to each person's unique genetic make-up and medical condition.

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

The global protein chip market revenue was US$ 652.8 million in 2020. The global protein chip market is forecast to reach US$ 1,367.1 million by 2030, growing at a compound annual growth rate (CAGR) ...

Views regarding the MIAME requirements range from a perception that they are insufficient 5, to opinions that any requirements to annotate public microarray data should be abandoned. One problem with ...

With high-dimensional data, variable-by-variable statistical testing is often used to select variables whose behavior differs across conditions. Such an approach requires adjustment for multiple ...

KFB - Center of Excellence for Fluorescent Bioanalysis integrates Genomatix GeneChip® Analysis-Pipeline into its product portfolio. Premium services offered for premium results Munich, Regensburg ...

A common goal of microarray and related high-throughput genomic experiments is to identify genes that vary across biological condition. Most often this is accomplished by identifying genes with ...

To determine whether increased androgen receptor protein concentration has a causal role in the hormone sensitive-to-hormone refractory transition, we introduced epitope-tagged wild-type AR cDNA, by ...